Qiagen JV Gets FDA OK for Blood Collection, Purification System | GenomeWeb

This article has been updated to clarify that Qiagen's joint venture PreAnalytix received the FDA clearance, and not Qiagen.

NEW YORK (GenomeWeb News) – PreAnalytix, a joint venture of Qiagen and Becton Dickinson, has received US Food and Drug Administration clearance for the automation of the PAXgene Blood RNA System on Qiagen's QIAcube platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.